ConductScience.org, home

Paper1649574

Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.

Pace J and 2 others. Antimicrob Agents Chemother, 1991. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424. Papers, record 1649574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1649574

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pace JJ
2Bertasso AA
3Georgopapadakou NHN H

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
Bacterial ProteinsMajor topic
CefotaximeMajor topic
CephalosporinsMajor topic
CiprofloxacinMajor topic
Escherichia coliMajor topic
FluoroquinolonesMajor topic
HexosyltransferasesMajor topic
Peptidyl TransferasesMajor topic
Anti-Bacterial Agents
Bacterial Outer Membrane Proteins
Carrier Proteins
Cell Membrane Permeability
Coliphages
DNA Replication
DNA, Bacterial
Drug Resistance, Microbial
Fleroxacin
Gene Expression Regulation, Bacterial
Microbial Sensitivity Tests
Muramoylpentapeptide Carboxypeptidase
Mutation
Penicillin-Binding Proteins
Porins
beta-Lactamases

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12107064In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.Chemotherapy1990https://conductscience.org/library/papers/2107064PubMed
23532944Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3532944PubMed
36317653Gene envY of Escherichia coli K-12 affects thermoregulation of major porin expression.J Bacteriol1984https://conductscience.org/library/papers/6317653PubMed
46086576Regulation of outer membrane protein synthesis in Escherichia coli K-12: deletion of ompC affects expression of the OmpF protein.J Bacteriol1984https://conductscience.org/library/papers/6086576PubMed
56294048Porin channels in Escherichia coli: studies with beta-lactams in intact cells.J Bacteriol1983https://conductscience.org/library/papers/6294048PubMed
66351733Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6351733PubMed
76703686Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6703686PubMed
87021759Effect on solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli.J Gen Physiol1981https://conductscience.org/library/papers/7021759PubMed
96973564After pro-drug -- mutual pro-drugs.J Antimicrob Chemother1981https://conductscience.org/library/papers/6973564PubMed
10334063Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/334063PubMed
114943178Replication and repair of DNA in cells of Escherichia coli treated with toluene.Proc Natl Acad Sci U S A1970https://conductscience.org/library/papers/4943178PubMed
122504106Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2504106PubMed
132782857In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2782857PubMed
142675755Mode of action of the dual-action cephalosporin Ro 23-9424.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2675755PubMed
152580479Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/2580479PubMed
162848006marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli.J Bacteriol1988https://conductscience.org/library/papers/2848006PubMed
172412244Role of permeability barriers in resistance to beta-lactam antibiotics.Pharmacol Ther1985https://conductscience.org/library/papers/2412244PubMed
183010850Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3010850PubMed
193132091Routes of quinolone permeation in Escherichia coli.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3132091PubMed
203056253Endogenous active efflux of norfloxacin in susceptible Escherichia coli.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3056253PubMed

See all 28 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
33435500The Odd Couple(s): An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group.Int J Mol Sci2021https://conductscience.org/library/papers/33435500PubMed
29540434Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?Clin Microbiol Rev2018https://conductscience.org/library/papers/29540434PubMed
8384817Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8384817PubMed
8067776beta-Lactamase hydrolysis of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8067776PubMed
1804005In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1804005PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1649574

GET https://conductscience.org/api/papers/v1/1649574/references?page=2